Immunicon Corporation (IMMC) Presented Advances in Rare Cell Technology at ISAC XXIV International Congress, May 17-21, 2008
5/22/2008 8:49:32 AM
HUNTINGDON VALLEY, Pa. & BUDAPEST, Hungary--(BUSINESS WIRE)--Immunicon Corporation (OTCBB:IMMC) made several presentations at the International Society for Analytical Cytology (ISAC) XXIV International Congress on advances in rare cell detection ranging from enhancements on CellTracks® imagery and enrichment technology; the elimination of operator variability by automating F.I.S.H. probe counting in circulating tumor cells; the ability to identify RSV infections in nasopharyngeal samples; and the monitoring of CD4 counts in HIV patients with a portable image cytometer. ISAC is the leading professional organization for scientists developing and utilizing multidisciplinary, advanced technology for the measurement of cells and cell processes. The annual meeting was held on May 17-21, 2008 in Budapest, Hungary.
comments powered by